...
首页> 外文期刊>Journal of biomedical materials research, Part A >Biodegradable balloon-expandable self-locking polycaprolactone stents as buckling explants for the treatment of retinal detachment: An in vitro and in vivo study
【24h】

Biodegradable balloon-expandable self-locking polycaprolactone stents as buckling explants for the treatment of retinal detachment: An in vitro and in vivo study

机译:可生物降解的球囊扩张型自锁聚己内酯支架作为屈曲外植体治疗视网膜脱离的体内和体外研究

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this report was to develop biodegradable balloon-expandable self-locking poly(e-caprolactone) (PCL) stents for the treatment of retinal detachment. To create the biodegradable stents, polycaprolactone components were first fabricated by a laboratory-scale microinjection molding machine. The components were then assembled into mesh-like stents of 6 and 8 mm in diameter. A special geometry of the components was designed to self-lock the assembled stents after being expanded by balloons. Characterization of the biodegradable PCL stents was carried out. PCL stents exhibited comparable mechanical properties with that of silicone sponge. Neither significant amount of collapse pressure reduction nor weight loss of the stents was observed after being submerged in phosphate buffered saline for 30 days. In addition, the stents were also implanted in the episcleral space of 10 New Zealand white rabbits. The stents were placed in radial direction and left unsutured after balloon expansion. The stents achieved an efficient buckling effect in echographic and fundus photographic examinations. The ocular pressure was significantly elevated after stent implantation and gradually normalized after the second week. The computed tomography studies verified the hypothesis of minimal migration of the PCL stents. The in vivo result suggests that balloon-expandable biodegradable stents can potentially serve as an ideal indenting biomaterial in retinal detachment surgery. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A:167175, 2013.
机译:本报告的目的是开发可生物降解的球囊扩张型自锁聚(e-己内酯)(PCL)支架,用于治疗视网膜脱离。为了制造可生物降解的支架,首先通过实验室规模的微注射成型机制造聚己内酯组件。然后将组件组装成直径为6和8毫米的网状支架。组件的特殊几何形状经设计可在气球膨胀后自动锁定组装好的支架。对可生物降解的PCL支架进行了表征。 PCL支架表现出与硅胶海绵相当的机械性能。将支架浸入磷酸盐缓冲液中30天后,既没有观察到明显的塌陷压力降低幅度,也没有发现支架的重量损失。另外,该支架也被植入10只新西兰白兔的巩膜间隙。支架沿径向放置,气囊扩张后不缝合。支架在超声检查和眼底照相检查中达到了有效的屈曲效果。植入支架后,眼压显着升高,第二周后逐渐恢复正常。计算机断层扫描研究证实了PCL支架最小移动的假说。体内结果表明,可球囊扩张的生物可降解支架在视网膜脱离手术中可以潜在地用作理想的压入生物材料。 (C)2012 Wiley Periodicals,Inc.J Biomed Mater Res Part A:101A:167175,2013。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号